AGA Supports Fecal Microbiota-Based Therapies for C Diff in

The guideline recommends fecal microbiota transplant in most cases of recurrent Clostridioides difficile infection but does not suggest fecal microbiota-based therapies for IBD or IBS.

Related Keywords

United States , American , Amanda Kabage , Anne Peery , University Of North Carolina School Medicine , American Gastroenterological Association , School Of Medicine Anne Peery , North Carolina School , Cochrane Central Register , Controlled Trials , Cochrane Database , Systematic Reviews , Ibd , Inflammatory Bowel Disease , Ribs , Irritable Bowel Syndrome , C Diff , Clostridioides Difficile , Infection , Cfmt , Fecal Microbiota Transplant ,